Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
38,844,993
-
Share change
-
+3,562,504
-
Total reported value
-
$46,983,012
-
Put/Call ratio
-
70%
-
Price per share
-
$1.21
-
Number of holders
-
74
-
Value change
-
+$4,282,053
-
Number of buys
-
27
-
Number of sells
-
30
Institutional Holders of TRANSENTERIX INC - COM NEW (TRXC) as of Q1 2017
As of 31 Mar 2017 TRANSENTERIX INC - COM NEW (TRXC) had 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 38,844,993 shares of stock of the company.
Largest 10 holders included Aisling Capital LLC, SV Health Investors, LLC, JPMORGAN CHASE & CO, BlackRock Inc., StepStone Group LP, VANGUARD GROUP INC, MASTERS CAPITAL MANAGEMENT LLC, STATE STREET CORP, INTERNATIONAL BIOTECHNOLOGY TRUST PLC, and NORTHERN TRUST CORP.
This table shows 74 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.